10% Owners Sell $1.23 Billion in Medline Stock Amid Ongoing Secondary Offerings
MDLN is trading near its 52-week low of $34.34 (3.3% above the low).
Summary
Multiple 10% owners, including Blackstone entities, reported the sale of over $1.23 billion worth of Medline Class A Common Stock, continuing a pattern of significant share distributions.
Key Events · Ownership and Investor Activity · MDLN
-
Significant Share Sale by 10% Owners
Multiple affiliated 10% owners, including Blackstone entities, disposed of $1.23 billion worth of Class A Common Stock on May 28, 2026.
-
Part of Ongoing Secondary Offerings
This sale is connected to a series of secondary offerings by major private equity shareholders, with over $7.5 billion in net sales over the last 90 days.
-
Stock Trading Near 52-Week Low
The disposition occurs while Medline's stock is trading near its 52-week low of $34.34, potentially exacerbating negative sentiment.
Analysis · MDLN · Industrial Applications And Services
This Form 4 details the sale of over $1.23 billion in Medline Class A Common Stock by several affiliated 10% owners, including Blackstone entities. This transaction, occurring on May 28, 2026, is part of a series of secondary offerings by these major shareholders, as evidenced by recent S-1 and 424B4 filings. The substantial sale, representing 2.625% of the company's market cap, adds to the ongoing selling pressure from institutional investors, who have collectively sold over $7.5 billion in the last 90 days. The stock is currently trading near its 52-week low, making these large dispositions particularly notable.
At the time of this filing, MDLN was trading at $35.47 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $47B. The 52-week trading range was $34.34 to $50.88. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.